Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
3.040
+0.030 (1.00%)
At close: Nov 4, 2024, 4:00 PM
3.060
+0.020 (0.66%)
Pre-market: Nov 5, 2024, 8:21 AM EST
Trevi Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Cash & Equivalents | 12.96 | 32.4 | 12.59 | 36.83 | 45 | 57.31 | Upgrade
|
| Short-Term Investments | 56.53 | 50.57 | 107.92 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 69.5 | 82.97 | 120.51 | 36.83 | 45 | 57.31 | Upgrade
|
| Cash Growth | -26.19% | -31.15% | 227.21% | -18.16% | -21.48% | 695.79% | Upgrade
|
| Other Receivables | - | - | - | - | - | 0.56 | Upgrade
|
| Receivables | - | - | - | - | - | 0.56 | Upgrade
|
| Prepaid Expenses | 1.8 | 3.62 | 0.8 | 0.89 | 1 | 1.68 | Upgrade
|
| Other Current Assets | 0.83 | 0.96 | 1.31 | 0.24 | 0.27 | - | Upgrade
|
| Total Current Assets | 72.13 | 87.55 | 122.62 | 37.96 | 46.27 | 59.55 | Upgrade
|
| Property, Plant & Equipment | 1.41 | 1.56 | 0.19 | 0.18 | 0.33 | 0.43 | Upgrade
|
| Other Long-Term Assets | 0.27 | 0.3 | 0.21 | 0.33 | 0.53 | 0.02 | Upgrade
|
| Total Assets | 73.81 | 89.4 | 123.02 | 38.48 | 47.13 | 60 | Upgrade
|
| Accounts Payable | 1.51 | 1.81 | 2.86 | 2.85 | 2.02 | 1.6 | Upgrade
|
| Accrued Expenses | 4.93 | 3.71 | 3.52 | 3.81 | 3.43 | 3.5 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | 7 | 5.95 | - | - | Upgrade
|
| Current Portion of Leases | 0.31 | 0.31 | 0.03 | 0.12 | 0.11 | 0.1 | Upgrade
|
| Total Current Liabilities | 6.75 | 5.82 | 13.4 | 12.72 | 5.56 | 5.2 | Upgrade
|
| Long-Term Debt | - | - | 2.15 | 8.65 | 13.95 | - | Upgrade
|
| Long-Term Leases | 0.88 | 1.03 | 0 | 0.02 | 0.14 | 0.26 | Upgrade
|
| Other Long-Term Liabilities | - | - | 0 | - | 0.2 | - | Upgrade
|
| Total Liabilities | 7.64 | 6.86 | 15.56 | 21.4 | 19.85 | 5.46 | Upgrade
|
| Common Stock | 0.07 | 0.07 | 0.06 | 0.03 | 0.02 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 328.57 | 321.64 | 317.59 | 197.96 | 174.24 | 168.75 | Upgrade
|
| Retained Earnings | -262.39 | -239.13 | -210.07 | -180.92 | -146.98 | -114.22 | Upgrade
|
| Comprehensive Income & Other | -0.08 | -0.03 | -0.12 | - | - | - | Upgrade
|
| Total Common Equity | 66.17 | 82.55 | 107.46 | 17.08 | 27.28 | 54.55 | Upgrade
|
| Shareholders' Equity | 66.17 | 82.55 | 107.46 | 17.08 | 27.28 | 54.55 | Upgrade
|
| Total Liabilities & Equity | 73.81 | 89.4 | 123.02 | 38.48 | 47.13 | 60 | Upgrade
|
| Total Debt | 1.19 | 1.34 | 9.18 | 14.74 | 14.21 | 0.36 | Upgrade
|
| Net Cash (Debt) | 68.3 | 81.63 | 111.33 | 22.09 | 30.79 | 56.96 | Upgrade
|
| Net Cash Growth | -26.30% | -26.68% | 404.06% | -28.27% | -45.94% | 839.88% | Upgrade
|
| Net Cash Per Share | 0.68 | 0.82 | 1.72 | 0.97 | 1.70 | 4.85 | Upgrade
|
| Filing Date Shares Outstanding | 72.59 | 68.96 | 60.05 | 30.81 | 19.91 | 17.83 | Upgrade
|
| Total Common Shares Outstanding | 72.59 | 68.28 | 59.94 | 28.51 | 18.55 | 17.83 | Upgrade
|
| Working Capital | 65.38 | 81.72 | 109.22 | 25.23 | 40.71 | 54.35 | Upgrade
|
| Book Value Per Share | 0.91 | 1.21 | 1.79 | 0.60 | 1.47 | 3.06 | Upgrade
|
| Tangible Book Value | 66.17 | 82.55 | 107.46 | 17.08 | 27.28 | 54.55 | Upgrade
|
| Tangible Book Value Per Share | 0.91 | 1.21 | 1.79 | 0.60 | 1.47 | 3.06 | Upgrade
|
| Machinery | - | 0.3 | 0.21 | 0.11 | 0.11 | 0.07 | Upgrade
|
| Construction In Progress | - | 0.02 | 0.05 | - | - | - | Upgrade
|
| Leasehold Improvements | - | 0.03 | 0.13 | 0.13 | 0.13 | 0.13 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.